Sociedad Andaluza de Enfermedades Infecciosas
Quick facts
Marketed products
- Triple therapy with ritonavir · Infectious Disease
Ritonavir is a protease inhibitor that blocks HIV protease, preventing the cleavage of viral polyproteins and maturation of infectious HIV particles.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: